Taq1A polymorphism and medication effects on inhibitory action control in Parkinson disease

BACKGROUND: Dopamine therapy in Parkinson disease (PD) can have differential effects on inhibitory action control, or the ability to inhibit reflexive or impulsive actions. Dopamine agonist (DAAg) medications, which preferentially target D2 and D3 receptors, can either improve or worsen control of i...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Brain Behav
Auteurs principaux: McDonell, Katherine E., van Wouwe, Nelleke C., Harrison, Madaline B., Wylie, Scott A., Claassen, Daniel O.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2018
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6043698/
https://ncbi.nlm.nih.gov/pubmed/29856137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.1008
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires